Director Steps Down Over Conflict of Interest in Lokahi Merger Implementation
GCTK is trading near its 52-week low of $2.18 (13% above the low).
Summary
Director Paul V. Goode resigned effective immediately, citing a potential conflict of interest between Glucotrack and its subsidiary over implementation of the Lokahi Therapeutics merger agreement.
Key Events · Executive and Board Changes · GCTK
-
Director Resignation
Paul V. Goode resigned from the Board effective September 14, 2026, with immediate effect.
-
Conflict of Interest Cited
Goode stated the resignation stemmed from a potential conflict of interest between the parent and subsidiary regarding implementation of the Lokahi Therapeutics merger agreement.
-
Governance Red Flag
The resignation adds a governance concern to an already distressed company that has disclosed going concern doubt, material weaknesses, and Nasdaq delisting risk.
-
Disclosure Process
The company provided Goode the opportunity to furnish a letter agreeing or disagreeing with the company's statements; any such letter will be filed as an amendment within two business days of receipt.
Analysis · GCTK · Industrial Applications And Services
Paul V. Goode resigned from Glucotrack's board effective September 14, 2026, citing a potential conflict of interest between the parent and subsidiary regarding implementation of the merger agreement with Lokahi Therapeutics. This is the first public disclosure of the resignation. The timing is notable: it comes just two months after the reverse merger closed and amid ongoing governance strain — the company has already disclosed going concern doubt, material weaknesses, and Nasdaq delisting risk. A director stepping down over merger-implementation conflicts adds a governance red flag to an already distressed situation.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1625 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCTK was trading at $2.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2M. The 52-week trading range was $2.18 to $136.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.